Literature DB >> 14563560

Specific gene inhibition by adenovirus-mediated expression of small interfering RNA.

Ling Jun Zhao1, Heng Jian, Henghu Zhu.   

Abstract

Specific gene inhibition in mammalian cells can be achieved by the use of small interfering RNA molecules (siRNA). These siRNA molecules can be chemically synthesized and transfected into cells, or directly expressed intracellularly from a plasmid DNA by the function of the cellular RNA polymerase III. We report here that the latter concept can be incorporated into an adenovirus vector to achieve specific gene inhibition in mammalian cells. As an examination of this approach, we have prepared an adenoviral vector capable of expressing siRNA molecules targeting p53 or VprBP/KIAA0800, a cellular protein that interacts with the HIV auxiliary protein Vpr. In both cases, specific reduction in the target protein level was observed after adenoviral infection. The reduction in the protein level was correlated with a specific reduction in the mRNA level. Since many cell types can be efficiently infected by adenoviruses, adenoviral vectors may serve as a useful alternative to other methods for siRNA delivery and gene inhibition, especially when the target cells are refractory to transfection by DNA or RNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563560     DOI: 10.1016/s0378-1119(03)00750-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  25 in total

1.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

Review 2.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

Review 3.  Therapeutic gene silencing in neurological disorders, using interfering RNA.

Authors:  G Scott Ralph; Nicholas D Mazarakis; Mimoun Azzouz
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

4.  Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.

Authors:  Zhe Chen; Ze-feng Xu; Jing-jia Ye; Hang-ping Yao; Shu Zheng; Jia-yi Ding
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

5.  Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway.

Authors:  Wei Feng; Yao Song; Chao Chen; Zhi Zhen Lu; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

6.  Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.

Authors:  Weizao Chen; Mingqiu Liu; Ye Jiao; Weiyao Yan; Xuefeng Wei; Jiulian Chen; Liang Fei; Yang Liu; Xiaoping Zuo; Fugui Yang; Yonggan Lu; Zhaoxin Zheng
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine.

Authors:  Wei Cong; Hong Jin; Chengda Jiang; Weiyao Yan; Mingqiu Liu; Jiulian Chen; Xiaoping Zuo; Zhaoxin Zheng
Journal:  Vet Res       Date:  2010-01-13       Impact factor: 3.683

8.  Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Authors:  Ge Li; Hyeon U Park; Dong Liang; Richard Y Zhao
Journal:  Retrovirology       Date:  2010-07-07       Impact factor: 4.602

9.  Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis.

Authors:  Xingxing Kong; Rui Wang; Yuan Xue; Xiaojun Liu; Huabing Zhang; Yong Chen; Fude Fang; Yongsheng Chang
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

10.  Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.

Authors:  Lei Sun; Ren-Feng Guo; Hongwei Gao; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2009-07-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.